Related references
Note: Only part of the references are listed.Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Validation of the Patient Health Questionnaire for Depression Screening Among the Elderly Patients in Taiwan
I-Peng Chen et al.
INTERNATIONAL JOURNAL OF GERONTOLOGY (2016)
Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed
Leslie Citrome
JOURNAL OF AFFECTIVE DISORDERS (2016)
A tool for sexual minority mental health research: The Patient Health Questionnaire (PHQ-9) as a depressive symptom severity measure for sexual minority women in Viet Nam
Trang Quynh Nguyen et al.
JOURNAL OF GAY & LESBIAN MENTAL HEALTH (2016)
Optimal cutoff point of the Hamilton Rating Scale for Depression according to normal levels of social and occupational functioning
Irene Romera et al.
PSYCHIATRY RESEARCH (2011)
A Randomized Controlled Trial of Sertraline for the Treatment of Depression in Persons With Traumatic Brain Injury
Teresa A. Ashman et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2009)
Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD)
Javier Ballesteros et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Structural validation of the Hamilton Depression Rating Scale
JC Cole et al.
JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT (2004)
Reliability and validity of the Turkish version of the Hamilton depression rating scale
A Akdemir et al.
COMPREHENSIVE PSYCHIATRY (2001)